USANA Health Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Common Stock And Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2018


	Three Months Ended
	April 1,	March 31,
	2017	2018

Net earnings available to common shareholders	$ 21,358	$ 28,946


Weighted average common shares outstanding - basic	24,499	24,074

Dilutive effect of in-the-money equity awards	477	199

Weighted average common shares outstanding - diluted	24,976	24,273


Earnings per common share from net earnings - basic	$ 0.87	$ 1.20

Earnings per common share from net earnings - diluted	$ 0.86	$ 1.19


Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that
their effect would be anti-dilutive:
	Three Months Ended
	April 1,	March 31,
	2017	2018
	2,179	1,802